# Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

> **NCT05490836** · NA · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **BIOLOGICAL:** PEG IFN α-2b; TAF
- **BIOLOGICAL:** PEG IFN α-2b; TAF

## Key facts

- **NCT ID:** NCT05490836
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2024-08
- **Final completion:** 2024-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05490836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05490836, "Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05490836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*